The Construction of Disease-Specific Reference Models and the Impact on Health Decision-Making
- VernacularTitle:疾病参考模型的构建及其在卫生决策中的作用
- Author:
Jie PAN
1
;
Wentao ZHU
;
Haijing GUAN
Author Information
1. 北京中医药大学 北京 100105
- Publication Type:Journal Article
- Keywords:
pharmacoeconomics;
disease-specific reference models;
healthcare and reimbursement decision-making;
evi-dence research
- From:
Chinese Health Economics
2025;44(3):9-14
- CountryChina
- Language:Chinese
-
Abstract:
As a tool for evaluating the value of drugs,Economic Evaluation(EE)models are playing an increasingly important role in healthcare and reimbursement decision-making in China.However,the lack of transparency and the uncertainty surrounding the results of these EE models have significantly hindered the translation of research evidence into policy decisions.Constructing a disease reference model provides a critical approach to address these challenges.First,starting from the concept of disease reference model,it compares its differences with traditional economics evaluation models and analyzes the key steps involved in their construc-tion;secondly,it takes advanced lung cancer,diabetes mellitus,and osteoporosis as typical cases to illustrate the main features and the current development of disease reference models;and it finally analyzes the advantages and challenges of the development of disease reference models in China.By systematically reviewing the methods and applications of disease reference models,it con-tributes to the exploration of future directions for economic evaluation models and promotes the high-quality development and deci-sion-making translation of pharmacoeconomics in China.
